Rejuveron Life Sciences raised $75m Series B equity and convertible loan financing, co-led by Catalio Capital Management and Apeiron Investment Group Biotech Financial Services Health services Pharma Investments 06 September 2023 Share: Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!
Round value (USD): 75M Round investors: Apeiron Investment GroupCatalio Capital ManagementMubadala Capital Company: Rejuveron Life Sciences Industry: BiotechFinancial ServicesHealth servicesPharma
Nuclidium in a €84M series B with Kurma Fund, Angelini Ventures, Wellington Partners, Neva SGR, DTCF, Bayern Kapital, Eurazeo, NRW and HighLight Capital Biotech Health services Manufacturing Pharma Investments 01 July 2025
Mosanna Therapeutics raised an $80M Series A round co-led by Pivotal bioVenture Partners and EQT, with Forbion, Broadview Ventures, and Norwest Ventures. Biotech Health services Investments 01 June 2025
ReproNovo raises $65 million in a series A round co-led by AXA IM Alts and M Ventures, joined by Ysios Capital, Jeito and ALSA Ventures Biotech Health services Pharma Software Services Investments 10 May 2025